Adoption of ‘Rolling Review’ for innovative drugs, shortening 6 months of approval process

Published: 2016-05-23 12:47:24

Updated: 2016-05-23 12:47:24

“The key feature of the Special Act is the ‘Rolling Review’ which exclusively review products indicated as innovative drugs. It’s completely different from the current Prompt Approval and Review System.”

The core of the ‘Special Act on Innovative Drug Development-Approval Support(hereinafter referring to Special Act)’ is adoption of the ‘Rolling Review’ concept which assigns exclusive reviewin...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.